Affiliation: | 1. Department of Oncology, Tampere University Hospital, Tampere, Finland;2. Medical Imaging Centre, Department of Radiology, Tampere University Hospital, Tampere, Finland;3. School of Medicine, University of Tampere, Tampere, Finland;4. Medical Imaging Centre, Department of Medical Physics, Tampere University Hospital, Tampere, Finland |
Abstract: | ObjectivesTo investigate whether diffusion-weighted imaging (DWI) apparent diffusion coefficient (ADC) correlates with prostate cancer aggressiveness and further to compare the diagnostic performance of ADC and normalized ADC (nADC: normalized to non-tumor tissue).Patients and methodsThirty pre-treatment patients (mean age, 69 years; range: 59–78 years) with prostate cancer underwent magnetic resonance imaging (MRI) examination, including DWI with three b values: 50, 400, and 800 s/mm2. Both ADC and nADC were correlated with the Gleason score obtained through transrectal ultrasound-guided biopsy.ResultsThe tumor minimum ADC (ADCmin: the lowest ADC value within tumor) had an inverse correlation with the Gleason score (r = –0.43, P < 0.05), and it was lower in patients with Gleason score 3 + 4 than in those with Gleason score 3 + 3 (0.54 ± 0.11 × 103 mm2/s vs. 0.64 ± 0.12 × 10?3 mm2/s, P < 0.05). Both the nADCmin and nADCmean correlated with the Gleason score (r = –0.52 and r = –0.55, P < 0.01; respectively), and they were lower in patients with Gleason score 3 + 4 than those with Gleason score 3 + 3 (P < 0.01; respectively). Receiver operating characteristic (ROC) analysis showed that the area under the ROC curve was 0.765, 0.818, or 0.833 for the ADCmin, nADCmin, or nADCmean; respectively, in differentiating between Gleason score 3 + 4 and 3 + 3 tumors.ConclusionTumor ADCmin, nADCmin, and nADCmean are useful markers to predict the aggressiveness of prostate cancer. |